A Spanish study's findings on causes of residual death in patients with AF on anticoagulation may come as a surprise.
NOACs No Longer Novel
A study of a global registry finds that prescriptions for direct oral anticoagulants have now surpassed those for VKAs. What do you Rx?
Dose-Adjusted DOACs: What Efficacy vs Warfarin?
Patients who require dose adjustment when taking direct oral anticoagulants have not been well studied. This large study is a good start.
When Atrial Fibrillation and Diabetes Coexist, How Best to Prevent Stroke?
In these complicated patients, should warfarin or a novel oral anticoagulant be chosen for stroke prevention?
Atrial Fibrillation During Pregnancy: Special Population Review
Is aspirin safe as antithrombotic therapy in pregnancy? Is electrocardioversion first-line treatment? Get the answers and other reminders, here.
ACC Consensus Statement: Cessation of Anticoagulants for Elective Procedures
Answers to 5 simple questions about your patient and the pending procedure create a pathway to decisions about perioperative anticoagulation.
Bridging the Death Gap: Residual Mortality in AF
A study from Spain identified causes of residual death in patients with AF on anticoagulation. The results may come as a surprise.
Diagnosis of Subclinical AF
Implantable cardiac monitoring devices now detect "silent" AF. But now that we "hear" it, what should we do?
Atrial Fibrillation Video: Symptoms, Cardioversion Strategies
A nurse describes his own bout with atrial fibrillation—the symptoms and his attempts to cardiovert to normal rhythm—from his hospital bed.
10 New Wonders of Wine
Tonic or poison? Elixir or toxin? These slides offer a quick review of the latest findings on the health pros and cons of imbibing.
Secondary AF: Risk of Recurrence Found in Framingham
Is new-onset AF linked to an acute precipitant less likely to recur than spontaneous AF? Is it any less dangerous? A new study finds answers in Framingham data.
Obesity and AF: A Dose-dependent Relationship
A recent literature analysis found a 10% to 29% excess risk for AF conferred by incremental increases in BMI. The study in 9 slides, here.
By clicking Accept, you agree to become a member of the UBM Medica Community.